Print Page   |   Contact Us   |   Report Abuse   |   Sign In   |   Register
Community Search
CASSS Associate Directors
Share |

Our Leadership

Board of Directors

Associate Directors

Distinguished Fellows


Assoc Directors Only



These are members of the CASSS charged with electing the Board and advising them on issues of importance to the membership-at-large.  

Associate Directors (ADs) are “statutory members” of CASSS.  Membership in this committee is open to all who have participated as a volunteer on any of the CASSS meeting committees and who actively parcticipate in AD activities. In most professional societies you pay dues to join the organization.  In this way, CASSS is unique.  Our “dues” are participation instead of a monetary payment.  CASSS' ADs are a select group of members, made up of those who care enough about the organization to not just send in an annual check but actually contribute their time and expertise.  This is what gives us our strength.  

Sid Advant, Kemwell Pharmaceuticals
Kris Antonsen, BioMarin Pharmaceutical, Inc.
Thomas Arroll, Seattle Genetics, Inc.
Yves Aubin, Health Canada
Evangelos Bakopanos, Health Canada
Alain Balland, Boehringer Ingelheim Pharma GmbH & Co. KG
Laura Bass, Bristol-Myers Squibb
Edna Betgovargez, AB SCIEX
Tim Blanc, Eli Lilly & Co.
Markus Blumel, Novartis Pharma AG
Michael  Brenowitz, Albert Einstein College of Medicine
Dave Carr, Bioanalytical Technologies
James Carroll, Pfizer, Inc.
Andrew Chang, Novo Nordisk Inc.
Emmanuelle Charton, EDQM, Council of Europe
Guodong  Chen, Bristol-Myers Squibb Company
Barry Cherney, Amgen Inc.
Steve Cohen, SAC Analytical Consultants
Mary Cromwell, Genentech, a Member of the Roche Group
Bob Cunico, Pacific Bio Labs
Francois de l'Escaille, Analis SA
Eef Dirksen, Synthon
JR Dobbins, Eli Lilly and Company
Vlad Dolnik, Alcor BioSeparations
John Dougherty, Eli Lilly & Company
Roman  Drews, rEVO Biologics
Julia Edwards, Biogen 
Bill Egan, Novartis
Franta Foret, Institute of Analytical Chemistry ASCR, v.v.i.
Beth Fowler 
Kathy Francissen, Genentech, a Member of the Roche Group
Michelle Frazier, AbbVie, Inc.
John Frenz, Alnylam Pharmaceuticals
András Guttman, University of Pannonia, Hungary
Jason  Hampson, Amgen, Inc.
Stephen Hartman, AbbVie Inc.
John Hennessey, NovaDigm Therapeutics, Inc.
John Hobbs, Beckman Coulter (Retired)
Damian Houde, Biogen 
Ping Hu, Janssen R&D, LLC
Chi-Ting Huang, Momenta Pharmaceuticals, Inc.
Brendan Hughes, Bristol Meyers Squibb
Ronald Imhoff, Janssen Biologics B.V.
Xu-Rong Jiang, MedImmune, a Member of the AstraZeneca Group
Ilias Jimidar, Johnson & Johnson Pharmaceutical R & D
Peter Johnson, 3M Drug Delivery Systems
Franka Kálmán, Haute Ecole Spécialisée de Suisse Occidentale
Jon Kauffman, Lancaster Labs
Steffen Kiessig, F. Hoffmann-La Roche Ltd
Bob Kuhn, Amgen, Inc.
Joe Kutza, MedImmune, a Member of the AstraZeneca Group
Tom Layloff, Supply Chain Management System
David Lee, Mersana Therapeutics
In Eui Lee, Kobe University
Vivian Lindo, MedImmune Limited
Aston Liu, GlaxoSmithKline Pharmaceuticals
Tony Lubiniecki, Centocor R & D, Inc.
Anders Lund, Genzyme Corporation
Henry Luo, Regeneron Pharmaceuticals
Yelena Lyubarskaya, Biogen Idec
Mirek Macka, ACROSS, Univ. of Tasmania
Helena Madden, Biogen 
Philip Marriott, Monash University
Noriyuki Matsumoto, JPMA
Bob Mattaliano, Genzyme Corporation
Kimberly May, Merck & Co., Inc.
Bruce Meiklejohn, Eli Lilly & Company
Thomas Millward, Novartis
Inger Mollerup, Novo Nordisk A/S
Ed Moore, University of Illinois
Jamie Moore, Genentech, a Member of the Roche Group
Gene Murano, Consultant
Linda Narhi, Amgen, Inc.
Wassim Nashabeh, F. Hoffmann - La Roche Ltd.
Shawn Novick, Seattle Genetics, Inc.
Brian Nunnally, Biogen
SungAe Park, Amgen, Inc.
David Passmore, Bristol-Myers Squibb
Joe Pesek, San Jose State University
Stefanie Pluschkell, Pfizer, Inc.
Chris Pohl, Thermo Scientific
Lesley Redfern, AbbVie, Inc.
Anthony Ridgway, Health Canada
Noel Rieder, Amgen, Inc.
Nadine Ritter, The Global Biotech Experts Collaborative, LLC
Jason Rouse, Pfizer, Inc.
Gerard Rozing, ROZING.COM
Meg Ruesch, Pfizer, Inc.
Reb Russell, Bristol-Myers Squibb
Richard Rustandi, Merck & Co., Inc.
Oscar Salas-Solano, Seattle Genetics, Inc.
Cari Sänger-van de Griend, Kantisto BV
Mark Schenerman, MedImmune, a Member of the AstraZeneca Group
Martin Schiestl, Sandoz GmbH
Timothy Schofield, MedImmune, a Member of the AstraZeneca Group
Thomas Schreitmueller, F. Hoffmann - La Roche Ltd.
Sally Seaver, Seaver Associates LLC
Joanne Severs, Bayer Healthcare
Karin Sewerin, BioPharmaLinx AB
Zahra Shahrokh, STC Biologics
Joe Siemiatkoski, Development Insights LLC
Satish Singh, Lonza AG
Bob Sitrin, PATH
Lance Smallshaw, UCB Biopharma sprl 
Zoran Sosic, Biogen
Kannan Srinivasan, Thermo Scientific
Arne Staby, Novo Nordisk A/S
Jeff Staecker, BioPhia
Bob Stevenson, ISC
Frank Svec, Lawrence Berkeley National Laboratory
Patrick Swann, Biogen
Jonathan Sweedler, University of Illinois
Garry Takle, MMD, Merck, Sharp and Dohme
Hansjoerg Toll, Sandoz GmbH
Kazuhisa Uchida, Kyowa Hakko Kirin Co., Ltd
Paul Varley, MedImmune Ltd.
Michael Washabaugh, MedImmune, a Member of the AstraZeneca Group
Ziping Wei, Novavax
Andy Weiskopf, Biogen
Will Weiss, Eli Lilly and Company
Jolanda Westerlaken, UCB Pharma SA
Phil Wyatt, Wyatt Technology Corporation
Yuan Xu, Gilead Sciences
Toyohiko Yamamoto, Asahi Kasei Pharma Corp.
Christopher  Yu, Genentech, a Member of the Roche Group
Heidi Zhang, Genentech, a Member of the Roche Group
Eike Zimmermann, Boehringer Ingelheim




more Calendar

1/23/2017 » 1/26/2017
CMC Strategy Forum and WCBP 2017

3/14/2017 » 3/17/2017
AT Europe 2017

4/3/2017 » 4/5/2017
HOS 2017

Featured Members

Membership Software Powered by YourMembership  ::  Legal